In addition, we also observed high G9a expression only in the Myc‐driven tumours (Fig. 1D), suggesting that the high global H3K9 mono‐ and di‐methylation signature is mediated by G9a, the key histone methyltransferase that catalyses this modification. The gene discussed is PRDM9; the disease is neoplasm.